Point72 Asset Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-97,500
Closed -$377K 4452
2026
Q1
$377K Sell
97,500
-300
-0.3% -$1.23K ﹤0.01% 3260
2025
Q4
$409K Buy
+97,800
New +$378K ﹤0.01% 3343

Other funds holding PGEN

Point72 Asset Management's PGEN Position: Q2 2026 in Review

Point72 Asset Management reduced its Precigen (PGEN) stake by 81% in Q2 2026, selling an estimated $23.2M and leaving 1,266,679 shares worth $7.22M. The position accounts for 0.01% of the portfolio, ranked #1508.

Point72 Asset Management first reported a position in PGEN in Q1 2023 and has held it in 5 quarters since. The position peaked at $57.4M in Q4 2025. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Point72 Asset Management held 1,266,679 shares of Precigen worth $7.22M as of Q2 2026.
  • Point72 Asset Management sold 5,377,682 Precigen shares in Q2 2026, an estimated $23.2M.
  • Precigen made up 0.01% of Point72 Asset Management's portfolio in Q2 2026, its #1508 holding.
  • Point72 Asset Management first reported a position in Precigen in Q1 2023 and has held it in 5 quarters since.
  • Point72 Asset Management's Precigen position peaked at $57.4M in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.